تداخل‌های دارویی
Deferasirox + Selexipag
شدت: متوسط
Deferasirox and Selexipag: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Selexipag is converted to its active metabolite partly through CYP2C8, and deferasirox inhibits CYP2C8 moderately. Exposure to the active metabolite may increase, leading to more prostacyclin-related adverse effects such as headache, diarrhea and jaw pain.
معنای این تداخل به زبان ساده
Deferasirox and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Deferasirox belongs to Miscellaneous; Selexipag belongs to Cardiovascular.
چرا رخ می‌دهد
Deferasirox inhibits CYP2C8, reducing metabolism of selexipag and its active metabolite.
اقدام لازم
Reduce selexipag to once-daily dosing while deferasirox is used. Watch for adverse effects and return to the usual schedule if deferasirox is stopped.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Deferasirox و Selexipag، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Deferasirox
تداخلات دیگر Selexipag
- Gemfibrozil + Selexipag منع مصرف
- Abiraterone + Selexipag متوسط
- Apalutamide + Selexipag متوسط
- Carbamazepine + Selexipag متوسط
- Clopidogrel + Selexipag متوسط
- Cyclosporin + Selexipag متوسط
پرسش‌های متداول
Can I take Deferasirox with Selexipag?
MediHelp rates the interaction as moderate. Deferasirox and Selexipag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Selexipag is converted to its active metabolite partly through CYP2C8, and deferasirox inhibits CYP2C8 moderately. Exposure to the active metabolite may increase, leading to more prostacyclin-related adverse effects such as headache, diarrhea and jaw pain.
How serious is the interaction between Deferasirox and Selexipag?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Reduce selexipag to once-daily dosing while deferasirox is used. Watch for adverse effects and return to the usual schedule if deferasirox is stopped.
What other medicines interact with Deferasirox?
MediHelp also lists interactions of Deferasirox with, for example, Acetylsalicylic acid, Alosetron, Aluminum hydroxide. The full list is on the Deferasirox page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
